Bronchodilators Increases Risk of Cardiovascular Events
(Ivanhoe Newswire) -- A study performed at the Institute for Clinical Evaluative Sciences, in Ontario, Canada, of older patients with COPD, suggests that new use of the long-acting bronchodilators β-agonists and anticholinergics were associated with similar increased risks of cardiovascular events.
Participants in the study were diagnosed with COPD and were at least 66 years old. Of the 191,005 eligible patients, 53,532 (28 percent) had a hospitalization or an emergency department visit for a cardiovascular event. According to the results, newly prescribed long-acting inhaled bronchodilators β-agonists and anticholinergics were associated with higher risk of a cardiovascular event compared with nonuse of those medications. The results also indicate there was no significant difference in events between the two medications.
For more information go to: http://media.jamanetwork.com/news-item/bronchodilators-appear-associated-with-increased-risk-of-cardiovascular-events/
SOURCE: JAMA Internal Medicine, May 2013
Click Here for a free weekly email with Ivanhoe's latest Medical Breakthroughs.